US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4002531A
(en)
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
ATE12348T1
(de)
|
1980-11-10 |
1985-04-15 |
Gersonde Klaus Prof Dr |
Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens.
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
US4433092A
(en)
|
1981-03-09 |
1984-02-21 |
Champion Spark Plug Company |
Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
JPS58118008A
(ja)
|
1982-01-06 |
1983-07-13 |
Nec Corp |
デ−タ処理装置
|
EP0088046B1
(fr)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipides en phase aqueuse
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
EP0102324A3
(fr)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipides et composés tensio-actifs en phase aqueuse
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
DE3486459D1
(de)
|
1983-09-26 |
1997-12-11 |
Udo Dr Med Ehrenfeld |
Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
|
US4615885A
(en)
|
1983-11-01 |
1986-10-07 |
Terumo Kabushiki Kaisha |
Pharmaceutical composition containing urokinase
|
US4694778A
(en)
|
1984-05-04 |
1987-09-22 |
Anicon, Inc. |
Chemical vapor deposition wafer boat
|
US4736866A
(en)
|
1984-06-22 |
1988-04-12 |
President And Fellows Of Harvard College |
Transgenic non-human mammals
|
WO1986000991A1
(fr)
|
1984-07-24 |
1986-02-13 |
Commonwealth Serum Laboratories Commission |
Procede de determination de mimotopes
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
EP0173494A3
(fr)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Récepteurs chimériques par liaison et expression de l'ADN
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
CA1319120C
(fr)
|
1985-04-01 |
1993-06-15 |
John Henry Kenten |
Lignee cellulaire myelomateuse transformee et expression d'un gene codant pour un polypeptide d'eucaryote a l'aide de cette lignee
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
EP0232262A4
(fr)
|
1985-08-15 |
1989-09-19 |
Stauffer Chemical Co |
Microorganisme producteur de tryptophane.
|
DE3650150T2
(de)
|
1985-08-16 |
1995-04-27 |
The Rockefeller University, New York, N.Y. |
Modulator der anabolischen Aktivität und seine Verwendungen.
|
US4870163A
(en)
|
1985-08-29 |
1989-09-26 |
New York Blood Center, Inc. |
Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
LU86128A1
(fr)
|
1985-10-18 |
1987-06-02 |
Vander Poorten Henri |
Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
|
WO1987002671A1
(fr)
|
1985-11-01 |
1987-05-07 |
International Genetic Engineering, Inc. |
Assemblage modulaire de genes d'anticorps, anticorps ainsi prepares et utilisation
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
JPH01502669A
(ja)
|
1987-03-13 |
1989-09-14 |
アムジエン・インコーポレーテツド |
精製された血小板由来の成長因子及びその精製方法
|
EP0307434B2
(fr)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Anticorps alteres
|
EP0682110A1
(fr)
|
1987-04-22 |
1995-11-15 |
Chiron Corporation |
ADN de recombinaison codant pour des polypeptides de la chaîne A de PDGF
|
EP0288088B1
(fr)
|
1987-04-24 |
1994-03-09 |
Teijin Limited |
Détection du facteur nécrosant de tumeur; anticorps monoclonal et composition
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
US5489425A
(en)
|
1987-06-24 |
1996-02-06 |
The Dow Chemical Company |
Functionalized polyamine chelants
|
US4994560A
(en)
|
1987-06-24 |
1991-02-19 |
The Dow Chemical Company |
Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
WO1989002468A1
(fr)
|
1987-09-11 |
1989-03-23 |
Whitehead Institute For Biomedical Research |
Fibroblastes transduits et leurs applications
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
ATE120454T1
(de)
|
1988-06-14 |
1995-04-15 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
AU634167B2
(en)
|
1988-06-24 |
1993-02-18 |
Dow Chemical Company, The |
Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
|
PT90959B
(pt)
|
1988-06-24 |
1995-05-04 |
Dow Chemical Co |
Processo para a preparacao de quelantes macrociclicos bifuncionais, de seus complexos e seus conjugados com anticorpos
|
US5756065A
(en)
|
1988-06-24 |
1998-05-26 |
The Dow Chemical Company |
Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
|
US5274119A
(en)
|
1988-07-01 |
1993-12-28 |
The Dow Chemical Company |
Vicinal diols
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
WO1990002809A1
(fr)
|
1988-09-02 |
1990-03-22 |
Protein Engineering Corporation |
Production et selection de proteines de liaison diversifiees de recombinaison
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5349052A
(en)
|
1988-10-20 |
1994-09-20 |
Royal Free Hospital School Of Medicine |
Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
US5342604A
(en)
|
1988-10-31 |
1994-08-30 |
The Dow Chemical Company |
Complexes possessing ortho ligating functionality
|
US5696239A
(en)
|
1988-10-31 |
1997-12-09 |
The Dow Chemical Company |
Conjugates possessing ortho ligating functionality and complexes thereof
|
JP2989002B2
(ja)
|
1988-12-22 |
1999-12-13 |
キリン―アムジエン・インコーポレーテツド |
化学修飾顆粒球コロニー刺激因子
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
ES2200016T3
(es)
|
1989-03-21 |
2004-03-01 |
Vical Incorporated |
Expresion de secuencias polinucleotidicas exogenas en un vertebrado.
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5324844A
(en)
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
EP0394827A1
(fr)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Polypeptides chimériques de CD4-immunoglobuline
|
ZA902949B
(en)
|
1989-05-05 |
1992-02-26 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
US5332671A
(en)
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
CA2017379C
(fr)
|
1989-05-24 |
2002-06-25 |
Kenneth A. Thomas, Jr. |
Purification et caracterisation d'un facteur de croissance derive de gliomes
|
US5808003A
(en)
|
1989-05-26 |
1998-09-15 |
Perimmune Holdings, Inc. |
Polyaminocarboxylate chelators
|
WO1991000360A1
(fr)
|
1989-06-29 |
1991-01-10 |
Medarex, Inc. |
Reactifs bispecifiques pour le traitement du sida
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
US5464764A
(en)
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
US5073627A
(en)
|
1989-08-22 |
1991-12-17 |
Immunex Corporation |
Fusion proteins comprising GM-CSF and IL-3
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
WO1991006570A1
(fr)
|
1989-10-25 |
1991-05-16 |
The University Of Melbourne |
MOLECULES RECEPTRICES Fc HYBRIDES
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
ES2087997T3
(es)
|
1990-01-12 |
1996-08-01 |
Cell Genesys Inc |
Generacion de anticuerpos xenogenicos.
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
EP0521985B1
(fr)
|
1990-03-20 |
1997-09-24 |
The Trustees Of Columbia University In The City Of New York |
Anticorps chimeriques utilisant des ligands de liaison de recepteurs a la place de leur region constante
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
ATE169030T1
(de)
|
1990-06-28 |
1998-08-15 |
Hoechst Ag |
Fusionsproteine mit immunglobulinanteilen, ihre herstellung und verwendung
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
DK0546073T3
(da)
|
1990-08-29 |
1998-02-02 |
Genpharm Int |
Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
IT1242149B
(it)
|
1990-09-27 |
1994-02-16 |
Consiglio Nazionale Ricerche |
Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
WO1992006180A1
(fr)
|
1990-10-01 |
1992-04-16 |
University Of Connecticut |
Ciblage de virus et de cellules pour leur inclusion selective dans des cellules
|
DK0553244T4
(da)
|
1990-10-05 |
2005-08-01 |
Celldex Therapeutics Inc |
Målrettet immunostimulering med bispecifikke reagenser
|
AU8727291A
(en)
|
1990-10-29 |
1992-06-11 |
Cetus Oncology Corporation |
Bispecific antibodies, method of production, and uses thereof
|
CA2095836C
(fr)
|
1990-11-09 |
1999-04-06 |
Stephen D. Gillies |
Immunoconjugues de la cytokine
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
AU643109B2
(en)
|
1990-12-14 |
1993-11-04 |
Cell Genesys, Inc. |
Chimeric chains for receptor-associated signal transduction pathways
|
DE69229454T2
(de)
|
1991-03-28 |
2000-01-05 |
Merck & Co., Inc. |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
DE69233367T2
(de)
|
1991-04-10 |
2005-05-25 |
The Scripps Research Institute, La Jolla |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
AP257A
(en)
|
1991-04-26 |
1993-06-03 |
Surface Active Ltd |
A method of releasing an antigen from an antibody and methods for their use in diagnosis and therapy.
|
ES2154637T3
(es)
|
1991-05-14 |
2001-04-16 |
Univ Connecticut |
Aportacion de genes dirigidos que codifican proteinas inmunogenicas.
|
EP0519596B1
(fr)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
Procédé pour réduire l'immunogénicité des domaines variables d'anticorps
|
AU2160992A
(en)
|
1991-06-05 |
1993-01-12 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Targeted delivery of genes encoding secretory proteins
|
CA2110799A1
(fr)
|
1991-06-14 |
1992-12-23 |
Arnold H. Horwitz |
Fragments d'anticorps d'origine microbienne, et conjugues
|
IL99120A0
(en)
|
1991-08-07 |
1992-07-15 |
Yeda Res & Dev |
Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US5641670A
(en)
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
US5428139A
(en)
|
1991-12-10 |
1995-06-27 |
The Dow Chemical Company |
Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
|
AU3434393A
(en)
|
1992-01-17 |
1993-08-03 |
Regents Of The University Of Michigan, The |
Targeted virus
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
US5399349A
(en)
|
1992-02-06 |
1995-03-21 |
Paunescu; Calin |
Treatment of acne
|
AU3737893A
(en)
|
1992-03-05 |
1993-10-05 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
JPH07505773A
(ja)
|
1992-04-03 |
1995-06-29 |
ヤング アレキサンダー ティー |
標的化されたウイルスベクターを用いた遺伝子治療
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
US5505931A
(en)
|
1993-03-04 |
1996-04-09 |
The Dow Chemical Company |
Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
|
WO1994004670A1
(fr)
|
1992-08-26 |
1994-03-03 |
President And Fellows Of Harvard College |
Utilisation de la cytokine ip-10 comme agent antitumeur
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
ES2157225T3
(es)
|
1992-10-09 |
2001-08-16 |
Advanced Tissue Sciences Inc |
Celulas hepaticas de reserva.
|
WO1994009137A1
(fr)
|
1992-10-15 |
1994-04-28 |
Genentech, Inc. |
Anticorps contre le recepteur du facteur de necrose de tumeurs de type 2
|
CA2146559A1
(fr)
|
1992-10-23 |
1994-05-11 |
Melanie K. Spriggs |
Methodes pour preparer des proteines oligomeres solubles
|
EP0673431A1
(fr)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Therapie genique de la fibrose kystique
|
TW402639B
(en)
|
1992-12-03 |
2000-08-21 |
Transkaryotic Therapies Inc |
Protein production and protein delivery
|
US5441050A
(en)
|
1992-12-18 |
1995-08-15 |
Neoprobe Corporation |
Radiation responsive surgical instrument
|
US5480971A
(en)
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
US5379578A
(en)
|
1994-01-25 |
1995-01-10 |
Agronomics, Inc. |
Green sugar cane billetting combine
|
DK1231268T3
(da)
|
1994-01-31 |
2005-11-21 |
Univ Boston |
Polyklonale antistofbiblioteker
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
WO1996004388A1
(fr)
|
1994-07-29 |
1996-02-15 |
Smithkline Beecham Plc |
Nouveaux composes
|
ATE364614T1
(de)
|
1994-11-07 |
2007-07-15 |
Human Genome Sciences Inc |
Tumornekrose-faktor-gamma
|
US5928939A
(en)
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
KR100654645B1
(ko)
|
1995-04-27 |
2007-04-04 |
아브게닉스, 인크. |
면역화된 제노마우스 유래의 인간 항체
|
WO1996034095A1
(fr)
|
1995-04-27 |
1996-10-31 |
Human Genome Sciences, Inc. |
Recepteurs du facteur de necrose tumorale chez l'homme
|
CA2219486A1
(fr)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Anticorps humains derives de xeno-souris immunisees
|
US5705151A
(en)
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
US5804162A
(en)
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US5811097A
(en)
|
1995-07-25 |
1998-09-22 |
The Regents Of The University Of California |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
DE19639601A1
(de)
|
1996-02-28 |
1997-09-04 |
Bayer Ag |
Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen
|
WO1997033904A1
(fr)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Recepteurs contenant un domaine de mort cellulaire
|
AU5711196A
(en)
|
1996-03-14 |
1997-10-01 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
WO1997034911A1
(fr)
|
1996-03-22 |
1997-09-25 |
Human Genome Sciences, Inc. |
Molecule ii inductrice d'apoptose
|
DE69733204T3
(de)
|
1996-07-15 |
2012-03-08 |
Chugai Seiyaku K.K. |
Neuartige vegf-ähnliche faktoren
|
JP2000516474A
(ja)
|
1996-08-16 |
2000-12-12 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
ヒトエンドカインα
|
ES2308787T3
(es)
|
1996-08-16 |
2008-12-01 |
Schering Corporation |
Antigenos de superficie de celular de mamiferos; reactivos relacionados.
|
EP0956339B1
(fr)
|
1996-08-23 |
2005-10-12 |
Ludwig Institute For Cancer Research |
Facteur d recombinant de croissance des cellules endotheliales vasculaires (vegf-d)
|
US6225290B1
(en)
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
KR20000052796A
(ko)
|
1996-10-25 |
2000-08-25 |
벤슨 로버트 에이치. |
뉴트로킨 알파
|
CA2722378C
(fr)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Anticorps humains qui se lient au tnf.alpha.
|
JP2001505060A
(ja)
|
1997-01-14 |
2001-04-17 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
腫瘍壊死因子受容体 5
|
BR9806954A
(pt)
|
1997-01-14 |
2000-03-21 |
Human Genome Sciences Inc |
Receptores 6a e 6b do fator de necrose tumoral
|
EP1012274B2
(fr)
|
1997-01-28 |
2011-06-15 |
Human Genome Sciences, Inc. |
Recepteur 4 (dr4:recepteur 4 de mort cellulaire) contenant des domaines de mort cellulaire, membre de la superfamille du recepteur du facteur de necrose tumorale (tnf) et se liant a la trail ( apo-2l)
|
ATE200030T1
(de)
|
1997-01-29 |
2001-04-15 |
Polymasc Pharmaceuticals Plc |
Pegylationsverfahren
|
CN1624128A
(zh)
|
1997-03-17 |
2005-06-08 |
人类基因组科学公司 |
包含死亡结构域的受体-5
|
CA2286879C
(fr)
|
1997-04-14 |
2003-12-16 |
Peter Kufer |
Nouveau procede de production de recepteurs d'anti-antigenes humains et leur utilisation
|
WO1998049305A1
(fr)
|
1997-05-01 |
1998-11-05 |
Amgen Inc. |
Polypeptides opg chimeres
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6214580B1
(en)
|
1997-05-30 |
2001-04-10 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
WO1998056892A1
(fr)
|
1997-06-11 |
1998-12-17 |
Human Genome Sciences, Inc. |
Recepteur humain tr9 du facteur de necrose tumorale
|